Viewing Study NCT06676293


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-05-07 @ 12:40 AM
Study NCT ID: NCT06676293
Status: COMPLETED
Last Update Posted: 2024-11-07
First Post: 2024-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma
Sponsor: Chang Gung Memorial Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Carcinoma (NPC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NPC View
None ICB View
None asparaginase View